Abstract
Return to work is critical goal following HSCT. However, late effects may impede return to normal activity after HSCT. In the case of inability to work, patients may need a work disability pension to ensure a reasonable livelihood. This study evaluated inability to work and need for disability pension among long-term survivors and analyzed possible determinants of need for social support. This retrospective, single-center study included all HSCT patients surviving ⩾5 years seen at the outpatient clinic between January 2013 and August 2015. There were 203 patients, median age at HSCT 35 years, and 50 years at time of study; median time between HSCT and study control was 12 years; 178 had allo-HSCT, 187 had a malignant disease. At time of study, 156 (77%) were working full or part-time, 47 (23%) were not working. In total, 76 (37%) survivors were receiving a work disability pension compared to 3.17% of the Swiss working population. Patients with a disability pension were significantly older at HSCT, were more often living alone, had more active physical and mental late effects, and higher score of fatigue compared to patients without. These findings underline the importance of screening for employment and the social consequences of non-employment in long-term survivors after HSCT.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hahn T, McCarthy PL Jr., Hassebroek A, Bredeson C, Gajewski JL, Hale GA et al. Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors. J Clin Oncol 2013; 31: 2437–2449.
Savani BN, Griffith ML, Jagasia S, Lee SJ . How I treat late effects in adults after allogeneic stem cell transplantation. Blood 2011; 117: 3002–3009.
Bhatia S, Francisco L, Carter A, Sun CL, Baker KS, Gurney JG et al. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. Blood 2007; 110: 3784–3792.
Martin PJ, Counts GW Jr., Appelbaum FR, Lee SJ, Sanders JE, Deeg HJ et al. Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation. J Clin Oncol 2010; 28: 1011–1016.
Sun CL, Kersey JH, Francisco L, Armenian SH, Baker KS, Weisdorf DJ et al. Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor study. Biol Blood Marrow Transplant 2013; 19: 1073–1080.
Kirchhoff AC, Leisenring W, Syrjala KL . Prospective predictors of return to work in the 5 years after hematopoietic cell transplantation. J Cancer Surviv 2010; 4: 33–44.
Mehnert A . Employment and work-related issues in cancer survivors. Crit Rev Oncol Hematol 2011; 77: 109–130.
Steiner JF, Cavender TA, Main DS, Bradley CJ . Assessing the impact of cancer on work outcomes: what are the research needs? Cancer 2004; 101: 1703–1711.
Khera N, Chang YH, Hashmi S, Slack J, Beebe T, Roy V et al. Financial burden in recipients of allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2014; 20: 1375–1381.
Denzen EM, Thao V, Hahn T, Lee SJ, McCarthy PL, Rizzo JD et al. Financial impact of allogeneic hematopoietic cell transplantation on patients and families over 2 years: results from a multicenter pilot study. Bone Marrow Transplant 2016; 51: 1233–1240.
Löf CM, Winiarski J, Ljungman P, Forinder U . The socioeconomic and psychosocial circumstances of adult long-term survivors of hematopoietic stem cell transplantation in childhood. Pediatr Transplant 2011; 15: 691–698.
de Boer AG, Taskila T, Ojajarvi A, van Dijk FJ, Verbeek JH . Cancer survivors and unemployment: a meta-analysis and meta-regression. JAMA 2009; 301: 753–762.
Stergiou-Kita M, Grigorovich A, Tseung V, Milosevic E, Hebert D, Phan S et al. Qualitative meta-synthesis of survivors' work experiences and the development of strategies to facilitate return to work. J Cancer Surviv 2014; 8: 657–670.
Kiserud CE, Fagerli UM, Smeland KB, Fluge Ø, Bersvendsen H, Kvaløy S et al. Pattern of employment and associated factors in long-term lymphoma survivors 10 years after high-dose chemotherapy with autologous stem cell transplantation. Acta Oncol 2016; 55: 547–553.
Morrison EJ, Ehlers SL, Bronars CA, Patten CA, Brockman TA, Cerhan JR et al. Employment status as an indicator of recovery and function one year after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2016; 22: 1690–1695.
Federal Statistical Office The Swiss Labour Force Survey 2015 in brief, In: (FDHA) FDoHAeditor. Federal Statistical Office: Neuchâtel, Switzerland, 2016 p. 1–28.
Kirsch M, Mitchell SA, Dobbels F, Stussi G, Basch E, Halter JP et al. Linguistic and content validation of a German-language PRO-CTCAE-based patient-reported outcomes instrument to evaluate the late effect symptom experience after allogeneic hematopoietic stem cell transplantation. Eur J Oncol Nurs 2015; 19: 66–74.
National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. DCTD, NCI, NIH, NHHS, (acccessed on 29 May 2009).
National Cancer Institute. Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0. DCTD, NCI, NIH, DHHS, (accessed on 9 August 2006).
Bresters D, van Gils IC, Kollen WJ, Ball LM, Oostdijk W, van der Bom JG et al. High burden of late effects after haematopoietic stem cell transplantation in childhood: a single-centre study. Bone Marrow Transplant 2010; 45: 79–85.
Schmid B, Buri M . Statistiken zur Sozialen Sicherheit: IV- Statistik 2014, In: BfSB Statistik (eds). Eidgenössisches Departement des Inneren EDI: Bern, Switzerland, 2015 pp. 1–43.
Bieri S, Roosnek E, Helg C, Verholen F, Robert D, Chapuis B et al. Quality of life and social integration after allogeneic hematopoietic SCT. Bone Marrow Transplant 2008; 42: 819–827.
Winterling J, Johansson E, Wennman-Larsen A, Petersson LM, Ljungman P, Alexanderson K . Occupational status among adult survivors following allo-SCT. Bone Marrow Transplant 2014; 49: 836–842.
Atkinson TCB, Marllier E, Nolan B Social Indicatores The EU and Social Inclusion. Oxford University Press: Oxford. UK, 2002. d.
Federal Statistical Office. Recipents of means-tested social benefits. Federal administration, Federal Department of Home Affairs.2014 Available at https://www.bfs.admin.ch/bfs/en/home/statistics/social-security/social-assistance/recipients-means-tested-social-benefits.html.
eurostat Statisics Explained. Social protection statistics-pension expenditure and pension beneficiaries2016. Available at http://ec.europa.eu/eurostat/statistics-explained/index.php/Social_protection_statistics_-_pension_expenditure_and_pension_beneficiaries-Data_sources_and_availability.
Karlsson NE, Carstensen JM, Gjesdal S, Alexanderson KA . Mortality in relation to disability pension: findings from a 12-year prospective population-based cohort study in Sweden. Scand J Public Health 2007; 35: 341–347.
Bjorkenstam C, Alexanderson K, Bjorkenstam E, Lindholm C, Mittendorfer-Rutz E . Diagnosis-specific disability pension and risk of all-cause and cause-specific mortality—a cohort study of 4.9 million inhabitants in Sweden. BMC Public Health 2014; 14: 1247.
Wallman T, Wedel H, Johansson S, Rosengren A, Eriksson H, Welin L et al. The prognosis for individuals on disability retirement. An 18-year mortality follow-up study of 6887 men and women sampled from the general population. BMC Public Health 2006; 6: 103.
Head J, Ferrie JE, Alexanderson K, Westerlund H, Vahtera J, Kivimaki M et al. Diagnosis-specific sickness absence as a predictor of mortality: the Whitehall II prospective cohort study. BMJ 2008; 337: a1469.
Popham F, Skivington K, Benzeval M . Why do those out of work because of sickness or disability have a high mortality risk? Evidence from a Scottish cohort. Eur J Public Health 2013; 23: 629–635.
Acknowledgements
We thank Alicia Rovó for her careful reading of the manuscript and her meaningful critical comments and suggestions.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Tichelli, A., Gerull, S., Holbro, A. et al. Inability to work and need for disability pension among long-term survivors of hematopoietic stem cell transplantation. Bone Marrow Transplant 52, 1436–1442 (2017). https://doi.org/10.1038/bmt.2017.115
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2017.115
This article is cited by
-
International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update
Bone Marrow Transplantation (2024)
-
Reduced prefrontal cortex and sympathetic nervous system activity correlate with fatigue after aHSCT
Bone Marrow Transplantation (2022)
-
Prevalence and Determinants of Return to Work as a Patient-Centered Outcome in Survivors of Hematopoietic Cell Transplantation
Current Hematologic Malignancy Reports (2022)
-
Predictors of return to work after autologous stem cell transplantation in patients with multiple myeloma
Bone Marrow Transplantation (2021)
-
Evaluation of quality of life and its influencing factors after transplantation of leukemia patients based on SF-36 score: a cohort study
Quality of Life Research (2020)